US FDA issues guidance for clinical trial endpoints for approval of cancer drugs and biologics

The US FDA has issued the final guidance on clinical trial endpoints for the approval of cancer drugs and biologics. This according to the industry is a major benefit for the companies that export products to both the

More From BioPortfolio on "US FDA issues guidance for clinical trial endpoints for approval of cancer drugs and biologics"